Abstract

Introduction: The Rabat regional blood transfusion center (TBC) delivers LBPs to the various healthcare establishments (HE). The pediatric oncology and hematology service (SHOP) represents the most important hematology and oncology service in Morocco.

The objective of this study is to assess the transfusion needs of the SHOP, the management of urgent requests and assess the feedback.

Materials and Methods: This is a three-month descriptive study, from December 1, 2018 to February 28, 2019, consists of collecting the data noted on medical prescriptions, verifying the compliance of blood requests, evaluating the feedback and the declaration adverse transfusion reactions (ATR). The sample of our study concerns polytransfused patients from SHOP.

Results and Discussion: During the period from December 1, 2018 to February 28, 2019, the Rabat TBC received 1174 applications with a total of 3834 LBPs requested.

The quantitative and qualitative satisfaction of blood requests reached 83.54%.

11.5% of the requests were urgent, mainly concern leukocyte-depleted platelets (75%).

As for the conformity of requests, 27% are non-compliant and hinder the smooth running of the service.

We also find that The Irregular Agglutinin Test (RAI) was positive in 1, 40%; the search time for compatible LBPs may exceed three days.

The traceability of delivered LBPs is weak and does not exceed 10.33%, the declaration of transfusion reactions is 1, 31/1000 LBPs delivered; this rate does not reflect the reality.

Conclusion: The management of polytransfused patients is a delicate mission, which requires close collaboration between the blood transfusion centre and health establishments. The availability of LBPs is the responsibility of the blood transfusion centre; the feedback and reporting of adverse reactions are the responsibility of the healthcare establishments.

Keywords: Pediatric; Hematology; Oncology; Blood Management; LBPs; Adverse Transfusion Reactions; Haemovigilance

References

1. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT) 3^rd
2. Agouzal M., et al. Revue de médicine pratique. Avril. Etude de la prévalence de l'enfant atteint de thalassémie au Nord-ouest du Maroc (2013).
3. Loi no 03-94 du 15 décembre 2005 relatifs aux règles de l’hémovigilance. Chapitre II du Bulletin Officiel Marocain no 5378.
4. https://www.hemovigilanccncrh.fr/www2/votre_region/basse_normandie/journee_formation/2_recommandation_de_bonne_pratique_has.pdf
5. Asma Rym Ben Romdhane., et al. “Evaluation des non-conformités des demandes de transfusion des concentres de globules rougesevaluation of non-compliance of transfusion requests of packedred blood cells”.
6. Damais-Cepitelli A., et al. “Evaluation qualitative de la prescription de produits sanguins labiles au groupe hospitalier du Havre”. Transfusion Clinique et Biologique 8 (2001): 77-84.
7. Le Niger and Lepiouf. “Evaluation des pratiques professionnelles sur les dysfonctionnements médicaux et paramédicaux repérés au cours du processus transfusionnel au CHU de Brest”. Transfusion Clinique et Biologique 14 (2007): 457-463.
8. “Transfusion of Blood and Blood Products: Indications and Complications”.
9. https://www.has-sante.fr/upload/docs/application/pdf/2015-02/transfusion_de_globules_rouges_homologues_-_produits_indications_alternatives_-_recommandations.pdf
10. sante.gov.ma Plan national de luttecontre les maladies hériditaire de l'hémoglobine (2012).
11. santé.gov.ma
12. S Achargui., et al “Identification of alloantibodies and their association: Balance sheet of 3 years at the regional center of blood transfusion in Rabat/Morocco and difficult in transfusion management”. Transfusion Clinique et biologique4 (2017): 422-430.
13. Bilanet perspective du fonctionnement de l’hemovigilance Françaiseet des donnéesreceuilliessur 9 ans. Transfusion Clinique et Biologique 10(2003):131-139.
14. S Ouadghiri., et al. Effetsindésirablesreceveurs à l’hôpitalIbnSina de Rabat: bilan 1999-2013Récipients adverse reactions in the IbnSina Hospital of Rabat: State 1999-2013.
15. ANSM 2019: Rapport d’activitéhémovigilance (2019).
16. SANJEEV SHARMA., et al. “Creighton University School of Medicine, Omaha, Nebraska”. American Family Physician 6 (2011): 719-724.

Citation

Citation: I Lemssahli., et al. “ Assessment of Transfusion Needs in Pediatric Hematology-oncology”. Acta Scientific Paediatrics 4.2 (2021): 47-52.

Copyright

Copyright: © 2021 I Lemssahli., et al This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.